Summary: To study transport of the carnitine precursor gamma-butyrobetaine (GBB) by rat liver-specific GABA transporter 2 (rGat2), we measured the uptake of deuterated GBB (d 3 -GBB) by Xenopus oocytes expressing rGat2. rGat2-mediated d 3 -GBB uptake was Na + and Cl ¹ dependent, and was saturable with a K m value of 70.6 « 34.8 µM. In carnitine transporter Octn2-deficient Jvs mice, mRNA expression of mGat3, the mouse ortholog of GAT2, decreased in liver, but increased in brain, while mRNA expression of mBbox1, which hydroxylates GBB to carnitine, increased in kidney and brain. These results indicate that GAT2 plays a role in transmembrane transport of GBB.
Introduction
Carnitine is a naturally occurring amino acid derivative essential for translocation of long-chain fatty acids into mitochondria for Ç-oxidation.
1,2¥ Intracellular carnitine deficiency, therefore, impairs mitochondrial Ç-oxidation, and this in turn halts production of ketone bodies as an energy source. Most of the carnitine requirement is fulfilled from the diet, e.g., from meat and dairy products, but the rest is biosynthesized from lysine and methionine, mainly in kidneys and liver in humans. 3¥ We have established that loss of renal Na ¦ -dependent, high-affinity carnitine transporter OCTN2 ¤SLC22A5¥ function causes primary systemic carnitine deficiency ¤SCD¥, 4¥ and the roles of several other transporters, including OCTNs, 4¥ ATB 0,¦ ¤SLC6A14¥, 5¥ and CT2 ¤SLC22A16¥, 6¥ in carnitine homeostasis and carnitine transport across plasma membranes have also been investigated. In mammals, carnitine is synthesized from È-butyrobetaine ¤GBB¥ by È-butyrobetaine dioxygenase ¤BBD, a product of the BBOX1 gene; also known as È-butyrobetaine hydroxylase, 2-oxoglutarate dioxygenase 1¥. 7¥ Since GBB is thought to be important for carnitine biosynthesis under carnitine-depleted conditions, we studied carrier-mediated GBB transport 8¥ and indicated an involvement of È-aminobutyric acid ¤GABA¥ transporter in GBB transport in rat hepatocytes. 9¥ In the present study, therefore, we demonstrate GBB transport by rat Gat2 ¤rGat2¥, which is distributed ubiquitously in non-neuronal tissues, by using rGat2-expressing Xenopus oocytes; we also showed alteration of the mouse ortholog of GAT2/rGat2, mGat3, and mBbox1 expression in major organs involved in carnitine biosynthesis in Octn2-deficient juvenile steatosis ¤Jvs¥ mice. These findings may provide a pharmacologically and pharmacokinetically important clue for supplementation of GBB as a carnitine precursor to treat patients with SCD.
Material and Methods
Materials: ª2,3-3 H«È-Aminobutyric acid ¤ª 3 H«GABA, 1.295 TBq/mmol¥ was purchased from Perkin-Elmer Life and Analytical Sciences ¤Boston, MA¥. GBB was deuterated ¤d 3 -GBB¥ as described previously. 9¥ All other reagents were obtained from Sigma-Aldrich ¤St. Louis, MO¥, Wako Pure Chemicals ¤Osaka, Japan¥, or Invitrogen ¤Carlsbad, CA¥.
Rat Gat2 cDNA cloning: The initial and latter parts of rGat2 cDNA were amplified from male Wistar rat liver total RNA by reverse transcription-PCR using Primestar DNA polymerase ¤Takara Bio Inc., Kyoto, Japan¥ with the following primers: sense 5$-ggcagaagcttgacagagtagcggctgca-3$ and antisense 5$-tgtgatgttggggtacaggtaa-3$, and sense 5$-gttgatccgaggagtaacactgc-3$ and antisense 5$-cccacatctagactcg-caggtgtgtcaa-3$, respectively. Finally, the two parts were ligated in pcDNA3.1¤¦¥ ¤Invitrogen¥ at HindIII and XbaI and then verified by a nucleotide sequencer ¤310 Genetic Analyzer, Applied Biosystems¥.
Uptake experiments in Xenopus laevis oocytes: rGat2 cRNA was prepared by in vitro transcription, and uptake experiments were performed as described previously. 10¥ Oocytes injected with 50 nL of the cRNA solution ¤1 µg/µL¥ or water were subjected to uptake experiments with uptake buffer ª88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO 3 , 0.82 mM MgSO 4 , 0.33 mM Ca¤NO 3 ¥ 2 , 0.41 mM CaCl 2 , and 10 mM 4-¤2-hydroxyethyl¥-1-piperazineethanesulfonic acid ¤HEPES¥, pH 7.4« containing ª 3 H«GABA ¤14 nM¥ or d 3 -GBB ¤10 µM¥ at room temperature for the designated time. At the end of the uptake period, the oocytes were washed off the substrate, and for ª 3 H«GABA, intracellular radioactivity was quantified with a liquid scintillation counter ¤Aloka, Tokyo, Japan¥. d 3 -GBB was quantified by LC-MS analysis as previously described.
9¥
Uptake ¤nL/oocyte¥ was calculated as the cell-to-medium ratio by dividing the uptake rate by the extracellular initial concentration of the substrates. The maximal rate ¤V max ¥ and the Michaelis-Menten constant ¤K m ¥ of rGat2-mediated d 3 -GBB uptake were estimated using KaleidaGraph ¤Synergy Software, Reading, PA¥ according to the following equation: V © ¤V max ' S¥/¤S ¦ K m ¥, where V is the uptake rate ¤pmol/oocyte/4 h¥, and S is the substrate concentration ¤µM¥.
Relative quantification of mRNA expression by quantitative RT-PCR ¤qRT-PCR¥: Jvs mice were bred and genotyped according to our previous report. 4¥ Total RNA was prepared from liver, kidney, and brain of Jvs mice and wild-type BL6/j mice. All animal experiments were carried out in accordance with the guidelines of Kanazawa University for the care and use of laboratory animals. mRNA expression of mGat3, mBbox1, and glyceraldehyde-3-phosphate dehydrogenase ¤mGapdh¥ was measured by qRT-PCR using gene-specific primers as follows: sense 5$-tgtgtggcttgggtttatgg-3$ and antisense 5$-cacagctggcgtgaaaaag-3$ for mGat3, sense 5$-tggatgggtttaacgtgtgc-3$ and antisense 5$-tgttgaagttgacgcgaacc-3$ for mBbox1, and sense 5$-tgttcctacccccaatgtgtc-3$ and antisense 5$-gcttcaccaccttcttgatgtc-3$ for Gapdh, as previously described. 11¥ The fold change in these genes, normalized to Gapdh and calculated relative to the expression in wild-type mouse cells, was analyzed by 2 %¼¼C T methods.
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Results
Functional expression of rGat2 in Xenopus oocytes: ª 3 H«GABA uptake was measured to confirm functional expression of rGat2 in transfected Xenopus oocytes. During a 60-min incubation, oocytes injected with rGat2 cRNA accumulated about 50-fold more ª 3 H«GABA than did water-injected oocytes ¤Fig. 1A¥. ª 3 H«GABA uptake linearly increased for 60 min and then reached a plateau after 90 min ¤Fig. 1B¥. ª 3 H«GABA uptake was almost completely abolished when Na ¦ was replaced with N-methyl-D-glucamine ¤NMDG ¦ ¥. In the absence of Cl % , the uptake decreased to 21.9% of control at 120 min. These results demonstrate functional expression of Gat2 in Xenopus oocytes. Furthermore, GBB reduced the ª 3 H«GABA uptake in a concentration-dependent manner ¤Fig. 1C¥, and its 50%-inhibitory concentration was estimated to be 36.5 + 5.7 µM, suggesting that GBB shares the binding site with GABA.
GBB uptake by Xenopus oocytes expressing rGat2: Next, deuterated GBB ¤d 3 -GBB¥ uptake was studied in Xenopus oocytes injected with rGat2. Since high background accumulation and/or cell-surface adsorption of d 3 -GBB in water-injected oocytes made it difficult to determine rGat2-mediated d 3 -GBB uptake, several compounds were tested for their ability to reduce the background without Gat2-mediated GBB Transportattenuating rGat2-mediated uptake. Among the compounds similar to GBB tested, carnitine at concentrations up to 200 µM was found to most efficiently reduce the background without affecting rGat2-mediated d 3 -GBB uptake ¤data not shown¥. In the following experiments, therefore, d 3 -GBB uptake was studied in Xenopus oocytes expressing rGat2 in the presence of 200 µM carnitine. d 3 -GBB uptake by rGat2-expressing oocytes increased in a time-dependent manner for up to 4 h ¤Fig. 2A¥. At 2 h, d 3 -GBB uptake by the oocytes was 2.1-fold greater than that by control oocytes. The kinetics of d 3 -GBB uptake by oocytes expressing rGat2 was examined during 2-h incubations with d 3 -GBB at concentrations from 10 to 800 µM ¤Fig 2B¥. The Gat2-specific uptake was saturable, with a Michaelis-Menten constant ¤K m value¥ of 70.6 + 34.8 µM and a maximum transport rate of 17.5 + 2.4 pmol/oocyte/4 h. Furthermore, to determine the ion dependency of Gat2-mediated GBB transport, Gat2-mediated d 3 -GBB uptake was measured in the absence of Na ¦ or Cl % . As shown in Figure 2C , the d 3 -GBB uptake was reduced to 2.71% of control uptake in the absence of Na ¦ ¤under otherwise standard conditions¥. In the absence of Cl % , the uptake was decreased to 10.6%. Thus, GBB was found to be a substrate of GAT2 and was transported in a Na ¦ -and Cl % -dependent manner. mRNA expression of mGat3 ¤mSlc6a13¥ in Jvs mice:
Since we previously showed that intravenous injection of GBB resulted in a two-fold increase of liver carnitine level in Jvs mice, but not in wild-type mice, 13¥ mGat3 ¤the mouse ortholog of hGAT2¥ was thought to play a role in supplying GBB as a precursor of carnitine biosynthesis to the organs where carnitine can be synthesized. Therefore, we next investigated mGat3 mRNA expression in wild-type and Jvs mice by means of qRT-PCR. Significant mRNA expression of mGat3 and mBbox1 was detected in all tissues tested. mRNA expression of mGat3 decreased in liver, but increased in brain. mBbox1 mRNA expression increased in both kidney and brain in Jvs mice. Based on qRT-PCR analysis, the log2 value of fold change of mGat3 expression in liver, kidney, and brain of Jvs mice over those of wild-type mice were %3.31 + 0.21, 0.31 + 0.11, and 0.77 + 0.11, respectively, while the corresponding values for mBbox1 mRNA expression were 0.39 + 0.21, 6.22 + 0.80, and 1.22 + 0.40, respectively ¤Fig. 3¥.
Discussion
The present study revealed for the first time that rGat2 plays a role in the transmembrane transport of GBB. At least four human GABA transporters have been identified to date, and all of them are SLC6 family members: GAT1 ¤SLC6A1¥, GAT2 ¤SLC6A13¥, GAT3 ¤SLC6A11¥, and BGT1 ¤SLC6A12¥. In rats, rGat1 and rGat3 are mainly expressed in the central nervous system, whereas rGat2 is distributed in liver and, to a lesser extent, in kidney and retina. Therefore, we hypothesized that Gat2 is a mediator of GBB transport that is not affected by betaine, because betaine is recognized only by rBgt1 among them. As shown in Figure 2 , rGat2-mediated GBB transport was characterized by the typical Na ¦ -and Cl % -dependence of GABA transporters. The K m value of rGat2-mediated GBB transport was estimated to be 70.6 µM, i.e., about 3-fold lower than the affinity of GABA for rGat2 ¤23 µM¥ as previously reported, 14¥ suggesting that GBB is a relatively low affinity substrate of rGat2. However, taking the high expression of rGat2 in liver into consideration, rGat2 likely plays a role in the influx of GBB to hepatocytes as a precursor of carnitine.
Carnitine is biosynthesized by hydrolysis of GBB by BBD, which is secreted into the systemic circulation and then taken up by almost every tissue via OCTN2 8¥ and to a lesser extent via ATB 0,¦ . 5¥ Loss of OCTN2 function causes SCD because of impaired reabsorption of carnitine in kidney. On the other hand, the tissue distribution of BBD varies among mammalian species: BBD activity has been detected in kidney, liver, and brain in humans. 15¥ In rodents it is almost exclusively found in liver, 16¥ although an earlier study had indicated its activity in kidneys. 17¥ Therefore, we considered whether mGat3 expression is upregulated in liver of Jvs mice because mGat3 compensates for the decreased carnitine influx. RT-PCR, however, showed that mGat3 mRNA expression significantly decreased in liver ¤Fig. 3¥, but was unchanged in kidney in Jvs mice. Surprisingly, mBbox1 mRNA expression increased 74.3-fold in kidney in Jvs mice compared with the wild type. GBB is synthesized in kidney, and the high activity of 6-N-trimethyllysine dioxygenase, which converts 6-N-trimethyllysine to 3-hydroxy-trimethyllysine as the first step of carnitine biosynthesis, has been reported. 16¥ Under normal conditions, GBB synthesized in kidney is transferred to the liver and then utilized to make carnitine. Increased mBbox1 and unchanged mGat3 expression observed in kidneys ¤Fig. 3¥ imply that the main organ of carnitine biosynthesis shifts from liver to kidney due to impaired liver function, such as steatosis, when carnitine is depleted. Furthermore, in brain of Jvs mice a significant increase of both mGat3 and mBbox1 was observed compared to wild mice. Acetylcarnitine is produced from carnitine and acetyl-CoA by carnitine O-acetyltransferase in mammalian brain and is then utilized to synthesize major neurotransmitters including acetylcholine and glutamate.
18¥
Such biosynthesis may be reduced in brain of patients with chronic fatigue syndrome because cerebral acetylcarnitine uptake is decreased. 19¥ Hence, increased gene expression may play a compensatory role in neurotransmitter biosynthesis by maintaining or enhancing carnitine influx and biosynthesis.
In conclusion, our present study demonstrates that rGat2 mediates Na ¦ -and Cl % -dependent GBB transport, suggesting that GAT2/rGat2 contributes at least in part to GBB uptake in tissues, where carnitine is synthesized. Furthermore, our results indicate that GAT2/Gat2 is involved in carnitine biosynthesis in the kidneys under carnitine-depleted conditions, although future study needs to be done to confirm its role. Based on our findings here, GAT2 may be an important target for the efficient delivery of GBB as a carnitine precursor to treat patients with SCD. 
